However, another study has reported that myeloid-derived miR-223 inhibits the release of IL-1β by preventing the activation of NLRP3 to alleviate experimental colitis (Zhou et al., 2015), suggesting that miR-223 may have complex functions in UC. Here, IL1B is linked to colitis.